The role of nasal corticosteroid treatment on Adenoid
Phase 2
- Conditions
- ????????? ???????.D10.6
- Registration Number
- IRCT201303069429N2
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
inclusion:children between 2-14 with hypertrophic adenoid
exclusion:corticostreoid therapy more than 1 month;children with anatomical defects in head and neck
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adenoid size. Timepoint: before and after 8 week of corticosteroid therapy. Method of measurement: clinical symptoms such as snoring ...and adenoid size.
- Secondary Outcome Measures
Name Time Method Clinical manifestation and neck radiography. Timepoint: before and 8 weeks after corticostreoidtherapy. Method of measurement: questionnaire.